Senior insider sale
Chief Medical Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$1.23M
453.75K shares
What this filing means
BOUDES POL F plans to sell 453.75K shares of GALECTIN THERAPEUTICS INC valued at approximately $1.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/4/2024ACC: 0001972481-24-000260
Officer· Chief Medical Officer
Since Mar 2020
453.75K
Shares to sell
$1.23M
Approx. market value
453.75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
Options
Cash
1/24/2024
16.25KOptions
Cash
1/26/2023
2.00Options
Cash
1/26/2023
37.50KOptions
Cash
1/24/2022
50KOptions
Cash
3/25/2021
50KOptions
Cash
3/12/2020
71.43KOptions
Cash
3/12/2020
228.57KTotal acquired453.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/24/2024 | Options Cash | 16.25K | — |
1/26/2023 | Options Cash | 2.00 | — |
1/26/2023 | Options Cash | 37.50K | — |
1/24/2022 | Options Cash | 50K | — |
3/25/2021 | Options Cash | 50K | — |
3/12/2020 | Options Cash | 71.43K | — |
3/12/2020 | Options Cash | 228.57K | — |
| Total | 453.75K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
453.75K
Market value
$1.23M
10/4/2024
Total
Units
453.75K
Value
$1.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/4/2024 | 453.75K | $1.23M | NASDAQ | Planned |
| Total | 453.75K | $1.23M | ||